Axial Biotech, Inc.

Axial Biotech, Inc. is focused on the use of genetics and the development of minimally invasive, motion preserving implants to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is the first company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices. In its initial product development initiative, Axial has made significant progress towards the discovery of a location in the human genome that is associated with adolescent idiopathic scoliosis.

Current Investors/Backers

Axial Biotech, Inc. is backed by a group of top tier investors including Johnson & Johnson Development Corporation, vSpring Capital and Ohio Biotech Group.


ATEL Portfolio News